Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

12.21
+0.02000.16%
Volume:684.44K
Turnover:8.42M
Market Cap:641.27M
PE:9.04
High:12.65
Open:12.07
Low:12.06
Close:12.19
52wk High:13.41
52wk Low:4.02
Shares:52.52M
Float Shares:51.26M
Volume Ratio:0.81
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.35
EPS(LYR):-3.5962
ROE:13.92%
ROA:5.27%
PB:1.10
PE(LYR):-3.40

Loading ...

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Dec 16

FDA Approves Emergent BioSolutions Winnipeg Facility for Raxibacumab Manufacturing

Reuters
·
Dec 12

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of Raxibacumab at Its Winnipeg, Canada Site

THOMSON REUTERS
·
Dec 12

Director Ronald Richard Sells Common Shares of Emergent BioSolutions Inc

Reuters
·
Dec 10

BUZZ-Bavarian Nordic rises on share buyback - 'positive signal' for investors

Reuters
·
Dec 02

Bid-Ask Spreads on Currencies Narrow as EBS Trade Resumes -- Market Talk

Dow Jones
·
Nov 28

BRIEF-Emergent Biosolutions Marks 10-Year Anniversary Of The U.S. FDA Approval Of Narcan® Nasal Spray And Reinforces Its Commitment To Increasing Naloxone Access

Reuters
·
Nov 18

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of Narcan® Nasal Spray and Reinforces Its Commitment to Increasing Naloxone Access

THOMSON REUTERS
·
Nov 18

Aptevo Therapeutics Director Grady Grant III Acquires Common Shares

Reuters
·
Nov 13

Emergent BioSolutions Announces Retirement of DR. Louis W. Sullivan From Board of Directors

THOMSON REUTERS
·
Nov 13

Press Release: Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Dow Jones
·
Nov 13

Director Sujata Tyagi Dayal Sells Common Shares of Emergent BioSolutions Inc

Reuters
·
Nov 11

Aptevo Therapeutics Unveils Preclinical Data for Trispecific Antibody APVO451 in Solid Tumors

Reuters
·
Nov 10

Aptevo Therapeutics reports third-quarter net loss of $7.5 million

Reuters
·
Nov 06

Aptevo Therapeutics Inc expected to post a loss of $2.09 a share - Earnings Preview

Reuters
·
Nov 03

Stock Track | Emergent BioSolutions Plummets 5.22% as One-Off Charge and Gloomy Outlook Weigh on Investor Sentiment

Stock Track
·
Oct 31

Stock Track | Emergent BioSolutions Plummets 5.22% as One-Off Charge and Gloomy Forecasts Overshadow Profitability

Stock Track
·
Oct 31

Emergent BioSolutions: Strong Financial Performance and Strategic Positioning Drive Buy Rating

TIPRANKS
·
Oct 31

Emergent BioSolutions (EBS): One-Off $42.1M Loss Clouds Return to Profit, Tests Bullish Narratives

Simply Wall St.
·
Oct 31

Emergent BioSolutions’ Earnings Call Highlights Strong Growth

TIPRANKS
·
Oct 31